1142192-03-7 | Methyl 6-bromo-2-chloronicotinate

Packsize	Purity	Availability	Price	Discounted Price
100mg	95%	in stock	$49.00	$35.00
250mg	95%	in stock	$60.00	$42.00
1g	95%	in stock	$173.00	$121.00
5g	95%	in stock	$760.00	$532.00
10g	95%	in stock	$1,319.00	$923.00
25g	95%	in stock	$2,625.00	$1,837.00

Description

• Catalog Number: AA13863
• Chemical Name: Methyl 6-bromo-2-chloronicotinate
• CAS Number: 1142192-03-7
• Molecular Formula: C7H5BrClNO2
• Molecular Weight: 250.4771
• MDL Number: MFCD11857730
• SMILES: COC(=O)c1ccc(nc1Cl)Br

Computed Properties

• Complexity: 179
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 12
• Hydrogen Bond Acceptor Count: 3
• Rotatable Bond Count: 2
• XLogP3: 2.7

Upstream Synthesis Route

Methyl 6-bromo-2-chloronicotinate is a versatile compound commonly used in chemical synthesis processes. One notable application of this compound is its use as a key intermediate in the synthesis of pharmaceuticals. Its unique structure and functional groups make it a valuable building block for the creation of various drug molecules.In organic synthesis, Methyl 6-bromo-2-chloronicotinate can participate in a range of reactions such as coupling, substitution, and cross-coupling reactions to introduce specific functional groups into target molecules. This compound’s strategic placement of bromine and chlorine atoms makes it particularly useful for creating complex drug scaffolds with improved biological activities.Furthermore, the high reactivity and selectivity of Methyl 6-bromo-2-chloronicotinate make it a preferred choice in the pharmaceutical industry for creating new drug candidates or modifying existing ones. Its compatibility with a variety of other reagents and solvents allows for efficient and controlled transformations, essential for producing high-quality pharmaceutical products.Overall, Methyl 6-bromo-2-chloronicotinate plays a crucial role in the synthesis of pharmaceutical compounds by enabling chemists to tailor specific molecular structures with precision, making it a valuable asset in medicinal chemistry research and drug development.